Clinical characteristics of lung cancer in patients with connective tissue disease associated interstitial lung disease: a brief report
Clinical Rheumatology · 2026-08 · 45 (8) · 5085-5091
DOI: 10.1007/s10067-026-08231-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 26.06.2026. Verfasst von Guohua Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Connective Tissue Diseases, Lung Neoplasms. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION/OBJECTIVE: Patients with connective tissue disease-associated interstitial lung disease (CTD-ILD) have an increased risk of developing lung cancer (LC).This study investigated whether non-receipt of immunosuppressive therapy is associated with LC risk in CTD-ILD patients and identified associated risk factors. METHODS: This retrospective study reviewed 262 patients with CTD-ILD. Patients were divided into an LC group (n = 29) and non-LC group (n = 233). Logistic regression identified risk factors for LC. RESULTS: Non-receipt of corticosteroids and/or immunosuppressants (OR 6.675; 95%CI 2.000-22.272; P = 0.002) and usual interstitial pneumonia (UIP) pattern (OR 2.845; 95% CI 1.077-7.519; P = 0.035) were independent risk factors for LC. Most LC patients were stage IV (58.6%). Patients with LC had significantly poorer survival than those without (median 22.3 vs. 168.9 months; HR 11.392; 95% CI 6.163-21.057; p < 0.001). CONCLUSIONS: Non-receipt of immunosuppressive therapy and UIP pattern are independently associated with LC risk in CTD-ILD. The poor prognosis and advanced stage at diagnosis emphasize the need for early LC detection. Key Points • The UIP pattern and non-receipt of immunosuppressive therapy were independently associated with LC risk, although these findings are not causal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
- Department of Rheumatology and Clinical Immunology, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. wyhxxtt@163.com.
Zitieren
APA
Zhang, G., Zhang, L., Jiang, M., Shen, Y., Luo, J., & Wang, Y. (2026). Clinical characteristics of lung cancer in patients with connective tissue disease associated interstitial lung disease: a brief report. Clinical Rheumatology, 45(8), 5085-5091. https://doi.org/10.1007/s10067-026-08231-7
Vancouver
Zhang G, Zhang L, Jiang M, Shen Y, Luo J, Wang Y. Clinical characteristics of lung cancer in patients with connective tissue disease associated interstitial lung disease: a brief report. Clinical Rheumatology. 2026;45(8):5085-5091. doi:10.1007/s10067-026-08231-7
BibTeX
@article{Zhang2026,
author = {Zhang, Guohua and Zhang, Lingling and Jiang, Minna and Shen, Yawen and Luo, Junli and Wang, Yuhua},
title = {Clinical characteristics of lung cancer in patients with connective tissue disease associated interstitial lung disease: a brief report},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {8},
pages = {5085--5091},
doi = {10.1007/s10067-026-08231-7}
}
EUVIMED